이상반응 보고
| VAERS ID | 1642055 |
|---|---|
| 성별 | 여성 |
| 나이 | 29세 |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | FD0932 |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-07-26 |
| 발병일 | 2021-07-26 |
| 상태 |
증상
- 혈액 검사(Blood test)
- 태아 사망(Foetal death)
- 임신 중 모성 노출(Maternal exposure during pregnancy)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
Test Date: 20210727; Test Name: Blood test; Result Unstructured Data: Test Result: routine blood tests, no results provided
증상 상세
Intrauterine death, affecting management of mother, antepartum.
; Maternal exposure during pregnancy; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) EudraVigilance-WEB, regulatory authority number DK-DKMA-WBS-0081295.
Sender's (Case) Safety Report Unique Identifier: DK-DKMA-ADR 25719935.
A 29-year-old female patient received bnt162b2 (Pfizer), dose 1 intramuscular on 26Jul2021 (Batch/Lot Number: FD0932) as dose 1, single at 29-year-old female for COVID-19 immunization.
The patient's medical history and concomitant medications were not reported.
The patient experienced maternal exposure during pregnancy on 26Jul2021.
On 27Jul2021, intrauterine death affecting management of mother antepartum was reported.
The outcome of intrauterine death was not recovered.
The events were considered medically significant.
The patient underwent lab tests and procedures which included blood test: routine blood tests, no results provided on 27Jul2021.
No follow-up attempts are possible.
No further information is expected.